Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
Analyst Buy
|
Mid-range Performer
403.2500
4.25
(
1.07
%)
NSE
Dec 03, 2025
10:20 AM
38.57% Gain from 52W Low
Volume:
1.8M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
09 Nov 2018
Analyst Buy
403.25
1.07%
Model Trading Portfolio | Buy Biocon Ltd
Buy:
Biocon Ltd.
by
Edelweiss
Edelweiss
Biocon Limited is an Indian biopharmaceutical company based in Bangalore, India.
Biocon Ltd. is trading above all available SMAs
More from Biocon Ltd.
Recommended
Market opens flat, Bansal Wire gets a Rs 203 cr show-cause notice
Trendlyne Marketwatch |
03 Dec 2025, 10:07AM
Five stocks to buy from analysts this week - December 2, 2025
The Baseline |
02 Dec 2025, 05:59PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020